Medication-info.com Search Menu

Dexamethasone Injection: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current since November 3, 2026
Strength:
4 mg/mL
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - Dexamethasone Injection

INSTRUCTIONS FOR USE

Figure 1: Outer Packaging and Prefilled Syringe

NOTES:

    • Do not introduce any other fluid into the syringe at any time.
    • Do not dilute for IV push.
    • Do not re-sterilize the syringe.
    • Do not use this product on a sterile field.
    • This product is for single dose only.
  1. 1. Inspect the outer packaging (blister pack) to confirm the integrity of the packaging. Do not use if the blister pack or the prefilled syringe has been damaged.
  2. 2. Remove the syringe from the outer packaging. (See Figure 2)
  3. Figure 2
  4. 3. Visually inspect the syringe. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
  5. 4. Twist off the syringe tip cap. Do not remove the label around the luer lock collar. (See Figure 3)
  6. Figure 3
  7. 5. Expel air bubble(s). Adjust the dose (if applicable).
  8. 6. Administer the dose ensuring that pressure is maintained on the plunger rod during the entire administration.
  9. 7. Discard the used syringe into an appropriate receptacle.

For more information concerning this drug, please call Fresenius Kabi USA, LLC at 1-800-551-7176.

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

The brand names mentioned in this document are the trademarks of their respective owners.

U.S. Patents 9731082, 10661018, and 11426522

www.fresenius-kabi.com/us

451612A

Revised: 9/2025

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 203129 · View the label on DailyMed

Revision date stated in the text: September 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Dexamethasone Injection

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Corticosteroid
Active ingredient Dexamethasone sodium phosphate 4 mg/mL
Dosage form Injection, solution
Route Intra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue
Marketing status listed in the FDA NDC Directory
Company (applicant) FRESENIUS KABI USA
FDA approval ANDA 203129Abbreviated New Drug Application (ANDA) – generic drug Approved September 30, 2015
Therapeutic equivalence (TE) code APCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 13 labelers list this drug on DailyMed
Drug shortage
  • Current since November 3, 2026
Recalls
  • February 4, 2026: Class II recall: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Packages (NDC)
Package
4 mg/mL – 1.00 ml in 1 syringe, glass / 1 in 1 blister pack / 24 in 1 carton

Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.